EloquiMed

EloquiMed Eloquimed is a boutique medical writing firm delivering high-impact regulatory and clinical documents for biotech, pharma, and CROs.

We specialize in IND/NDA submissions, protocols, CSRs, IBs, and scientific communications, with deep expertise in oncology, CNS, and rare diseases. Our senior-only model ensures scientific rigor, speed, and compliance—helping lean teams meet milestones with confidence.

🔬 Regulatory Update: FDA Final Guidance on Decentralized TrialsDecentralized clinical trials (DCTs) are no longer just a...
08/28/2025

🔬 Regulatory Update: FDA Final Guidance on Decentralized Trials

Decentralized clinical trials (DCTs) are no longer just a concept. They are now a regulatory reality. The FDA has released final guidance outlining how sponsors and investigators must adapt trial design and documentation for decentralized settings.

Key takeaways for medical writers:
• 📑 Clearly document remote data collection methods and data origin
• 🧪 Define responsibilities for investigators vs. technology providers
• 🏥 Maintain clarity on which visits are remote vs. on-site in protocols and schedules of activities
• 🔎 Ensure documents are inspection-ready despite distributed trial models

At Eloquimed, we help biotech teams adapt protocols, IBs, and CSRs to meet these evolving expectations while keeping submissions compliant and timelines intact.

👉 Is your team preparing for a decentralized trial? Let’s talk about how writing strategy can keep you ahead.

🔎 Regulatory Writing Tip of the MonthInvestigator’s Brochures (IBs) are living documents that evolve with every stage of...
08/23/2025

🔎 Regulatory Writing Tip of the Month

Investigator’s Brochures (IBs) are living documents that evolve with every stage of development.
A lean, modular format can:
✔️ Accelerate updates
✔️ Reduce reviewer burden
✔️ Prevent submission delays

At Eloquimed, our senior-level writers specialize in designing IBs that balance clarity with scientific rigor, streamline sponsor and regulator workflows, and support faster development timelines.

📢 Preparing IBs or protocols? Eloquimed can partner with you.
🌐 www.eloquimed.com

Clinical Study Reports: Turning Data Into Regulatory SuccessAt Eloquimed, we know that a well-written Clinical Study Rep...
08/20/2025

Clinical Study Reports: Turning Data Into Regulatory Success

At Eloquimed, we know that a well-written Clinical Study Report (CSR) is more than just a regulatory requirement, it’s the bridge between raw clinical data and a compelling, compliant story of your therapy’s journey.

📄 What makes CSRs so critical?
They transform complex trial datasets into a clear, structured document aligned with ICH E3 standards.
They provide regulators, investigators, and partners with transparent evidence of safety and efficacy.
They serve as the foundation for future submissions, publications, and product positioning.

💡 Our Approach at Eloquimed
Accuracy + Compliance: Every CSR we deliver meets FDA, EMA, and global regulatory expectations.
Senior-Level Expertise: No junior handoffs—our physician-led team ensures every word is grounded in clinical context.

Efficiency Without Compromise: Typical timelines of 4–6 weeks from kickoff to finalization, with QC built in at every step.

Therapeutic Strengths: Oncology, CNS, rare diseases, and gene therapies.
We’ve supported CSRs for early-phase oncology programs, rare disease trials, and pivotal studies—always with the same goal: helping biotech and pharma teams deliver regulatory-ready documents with clarity and speed.

🚀 If your team is preparing for a submission or facing tight CSR timelines, Eloquimed can step in as your partner.

👉 Let’s connect to discuss how we can support your upcoming clinical and regulatory milestones.

Address

McLean, VA

Opening Hours

Monday 9am - 5am
Tuesday 9am - 5am
Wednesday 9am - 5am
Thursday 9am - 5am
Friday 9am - 5am

Telephone

+17084004297

Website

Alerts

Be the first to know and let us send you an email when EloquiMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EloquiMed:

Shortcuts

Share

Category